U.S., Sept. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07795749) titled 'Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B)' on Aug. 26.
Brief Summary: This is a phase II open-label, basket clinical trial to assess the feasibility of systemic and Intraperitoneal chemotherapy in subjects with Gastrointestinal Malignancies with Peritoneal Carcinomatosis. These are subjects who have a proven primary carcinoma of the digestive tract..
Study Start Date: Aug. 04
Study Type: INTERVENTIONAL
Condition:
Esophageal Carcinoma
Gastric Cancer (Diagnosis)
Colorectal Adenocarcinoma
Appendiceal Adenocarcinoma
Small Bowel Adenocarcinoma
Hepatobiliary Carcinoma in Situ
I...